TRAXV — First Tracks Biotherapeutics Inc

TRAXVFirst Tracks Biotherapeutics Inc

17.18USD+2.33%Mkt Cap: 782.20M USDP/E: —Last update: 2026-05-22

First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biothe…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap782.20M USD

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-163.71M USD

Revenue/Share—

Last Price17.18 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B—

EPS (TTM)—

EPS (Forward)—

52W Range

14.7920% of range26.80

52W High26.80 USD

52W Low14.79 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-41.80%

ROA-37.05%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-125.81M USD

CapEx (TTM)358.00K USD

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.04

Current Ratio—

Quick Ratio—

Book Value/Sh—

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.34.75M

Float—

Insiders—

Institutions—

Technical

SMA 5021.41 (-19.7%)

SMA 20021.41 (-19.7%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)446.28K

Avg Vol (10d)396.72K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—